Analysen zu Hermès (Hermes International)
| 04.07.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 04.07.24 | Hermès Buy | UBS AG | |
| 04.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | Hermès Buy | UBS AG | |
| 19.06.24 | Hermès Outperform | Bernstein Research | |
| 31.05.24 | Hermès Hold | Deutsche Bank AG | |
| 28.05.24 | Hermès Outperform | Bernstein Research | |
| 20.05.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 26.04.24 | Hermès Hold | Deutsche Bank AG | |
| 26.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | Hermès Halten | DZ BANK | |
| 25.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 25.04.24 | Hermès Buy | UBS AG | |
| 25.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 11.04.24 | Hermès Overweight | Barclays Capital | |
| 10.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Hermès Buy | UBS AG | |
| 08.03.24 | Hermès Buy | UBS AG | |
| 01.03.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 29.02.24 | Hermès Overweight | Barclays Capital | |
| 13.02.24 | Hermès Halten | DZ BANK | |
| 12.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Market-Perform | Bernstein Research | |
| 09.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | Hermès Overweight | Morgan Stanley | |
| 19.01.24 | Hermès Buy | UBS AG | |
| 11.01.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 11.01.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 10.01.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Hermès Buy | UBS AG | |
| 13.12.23 | Hermès Neutral | JP Morgan Chase & Co. | |
| 07.12.23 | Hermès Hold | Deutsche Bank AG | |
| 01.12.23 | Hermès Market-Perform | Bernstein Research | |
| 21.11.23 | Hermès Buy | UBS AG | |
| 30.10.23 | Hermès Overweight | Barclays Capital | |
| 25.10.23 | Hermès Hold | Deutsche Bank AG | |
| 24.10.23 | Hermès Neutral | JP Morgan Chase & Co. | |
| 24.10.23 | Hermès Buy | UBS AG | |
| 12.10.23 | Hermès Sell | Goldman Sachs Group Inc. | |
| 03.10.23 | Hermès Buy | UBS AG | |
| 26.09.23 | Hermès Equal-weight | Morgan Stanley | |
| 14.09.23 | Hermès Overweight | Barclays Capital | |
| 08.09.23 | Hermès Market-Perform | Bernstein Research | |
| 01.09.23 | Hermès Buy | UBS AG | |
| 22.08.23 | Hermès Halten | DZ BANK | |
| 02.08.23 | Hermès Overweight | Barclays Capital |
Aktuelle Aktienanalysen
| 08:41 | Novo Nordisk Buy | UBS AG | |
| 08:39 | Heidelberg Materials Buy | Deutsche Bank AG | |
| 08:39 | UBS Outperform | RBC Capital Markets | |
| 08:39 | RATIONAL Hold | Deutsche Bank AG | |
| 08:38 | Deutsche Bank Outperform | RBC Capital Markets | |
| 08:29 | LANXESS Buy | Deutsche Bank AG | |
| 07:54 | AIXTRON Hold | Jefferies & Company Inc. | |
| 07:54 | SUSS MicroTec Hold | Jefferies & Company Inc. | |
| 07:53 | ASML NV Buy | Jefferies & Company Inc. | |
| 07:53 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 07:53 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 07:52 | Infineon Buy | Jefferies & Company Inc. | |
| 07:50 | KION GROUP Outperform | Bernstein Research | |
| 07:49 | Jungheinrich Outperform | Bernstein Research | |
| 07:11 | Ahold Delhaize Equal Weight | Barclays Capital | |
| 07.04.25 | TRATON Neutral | JP Morgan Chase & Co. | |
| 07.04.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Nutrien Neutral | UBS AG | |
| 07.04.25 | Ahold Delhaize Hold | Jefferies & Company Inc. | |
| 07.04.25 | Evonik Neutral | UBS AG | |
| 07.04.25 | LANXESS Neutral | UBS AG | |
| 07.04.25 | WACKER CHEMIE Buy | UBS AG | |
| 07.04.25 | ING Group Buy | UBS AG | |
| 07.04.25 | Deutsche Bank Buy | UBS AG | |
| 07.04.25 | Befesa Buy | Jefferies & Company Inc. | |
| 07.04.25 | Fraport Neutral | UBS AG | |
| 07.04.25 | Apple Neutral | UBS AG | |
| 07.04.25 | Roche Buy | UBS AG | |
| 07.04.25 | Gerresheimer Kaufen | DZ BANK | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Sanofi Hold | Deutsche Bank AG | |
| 07.04.25 | Novartis Buy | Deutsche Bank AG | |
| 07.04.25 | GSK Hold | Deutsche Bank AG | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | BNP Paribas Outperform | RBC Capital Markets | |
| 07.04.25 | Brenntag Add | Baader Bank | |
| 07.04.25 | FUCHS Add | Baader Bank | |
| 07.04.25 | Givaudan Add | Baader Bank | |
| 07.04.25 | FedEx Buy | Deutsche Bank AG | |
| 07.04.25 | Symrise Add | Baader Bank | |
| 07.04.25 | KWS SAAT Buy | Baader Bank | |
| 07.04.25 | Fresenius Market-Perform | Bernstein Research | |
| 07.04.25 | WACKER CHEMIE Add | Baader Bank | |
| 07.04.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 07.04.25 | K+S Add | Baader Bank | |
| 07.04.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 07.04.25 | Roche Sell | Deutsche Bank AG | |
| 07.04.25 | TUI Market-Perform | Bernstein Research | |
| 07.04.25 | London Stock Exchange Buy | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.